期刊文献+

适形放疗联合化疗治疗局限期小细胞肺癌的临床疗效观察 被引量:5

Observation of clinical effect of conformal radiotherapy combined with chemotherapy in the treatment of patients with limited-stage small cell lung cancer
下载PDF
导出
摘要 目的探讨适形放疗联合化疗治疗局限期小细胞肺癌的临床疗效。方法选取在我院接受治疗的局限期小细胞肺癌患者共63例,随机分为观察组33例,对照组30例。观察组为放、化疗同步疗法。对照组为放、化疗序贯疗法。结果治疗后,观察组与对照组的治疗总有效率分别为93.9%、83.3%,比较发现,观察组的总有效率明显高于对照组(P<0.05)。随访两年中,观察组与对照组1、2年的生存率分别为81.8%(27/33)、70.0%(21/30)与72.7%(24/33)、36.7(11/30),差异具有统计学意义(P<0.05)。治疗过程中,观察组患者出现毒副反应的情况略高于对照组,但差异不具有统计学意义(P>0.05)。结论适形放疗联合化疗治疗局限期小细胞肺癌疗效显著,安全可靠。 Objective To investigate the clinical effect of conformal radiotherapy combined with chemotherapy in the treatment of patients with limited stage small cell lung cancer. Methods 63 patients with limited stage small cell lung cancer were randnmly divided into the observation group (33 cases) and the control group (30 cases). The observation group was treated with chemotherapy concurrent therapy, and the control group was treated with chemotherapy sequential therapy. Results After the treatment, the total effective rate was 93.9% and 83.3% in the observation group and the control group respectively (P 〈 0. 05). The survival rates of 1-year and 2-year tbl- low-up were 81.8% (27/33), 70% (21/30) and 72.7% (24/33), 36.7 (11/30) respectively in the observation group and in the control group. During the treatment course, the incidence of adverse reactions was slightly higher in the observation group than in the con- tml group, but without significant difference (P 〉 0. 05). Conclusion The curative effect of radiotherapy combined with chemotherapy in the treatment of patients with limited stage small cell lung cancer is remarkable, safe and reliable, and it is worthy of popularization and application.
出处 《临床肺科杂志》 2013年第10期1872-1873,共2页 Journal of Clinical Pulmonary Medicine
关键词 三维适形放疗 局限期 小细胞肺癌 疗效 three-dimensional conformal radiotherapy limited stage small cell lung cancer curative effect
  • 相关文献

参考文献6

二级参考文献63

  • 1李勤,吴湘阳,杨怡萍,亓芳迎,李洁,高飞,周梅林,王昕苗,冯丽,李青.非小细胞肺癌适形放疗的生存分析[J].现代肿瘤医学,2008,16(11):1933-1935. 被引量:1
  • 2于金明,任瑞美,袁明智,尹勇,岳金波.早期非小细胞肺癌三维适形放疗剂量分割研究[J].中华放射肿瘤学杂志,2005,14(3):158-161. 被引量:29
  • 3王颖杰,王绿化,陈东福,周宗玫,欧广飞,梁军,张可,殷蔚伯.小细胞肺癌的三维适形放射治疗[J].中华肿瘤杂志,2005,27(9):570-572. 被引量:12
  • 4Socinski MA,Bngart JA.Limited-stage small-cell lung cancer:the current status of combined-modality therapy.J Clin Oncol,2007,25:4137-4145.
  • 5Ettinger DS,Berkey BA,Abrams RA,et al.Study of paclitaxel,etoposide and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer:a radiation therapy oncology group 9609 phase Ⅱ study.J Clin Oncol,2005,23:4991-4998.
  • 6Erridge SC,Murray N.Thoracic radiotherapy for limited-stage small cell lung cancer:issues of timing,volume,doses,and fraction.Semin Oncol,2003,30:26-37.
  • 7Mohan A,Goyal A,Singh P,et al.Survival in small cell lung cancer in India:prognostic utility of clinical features,laboratory parameters and response to treatment.Indian J Cancer,2006,43:67-74.
  • 8De Ruysscher D,Bremer BH,Koppe F,et al.Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer:a phase Ⅱ trial.Radiother Oncol,2006,80:307-312.
  • 9Bass P,Belderbos JS,Senan S,et al.Concurrent chemotherapy (carboplatin,paclitaxel,etoposide) and involved-field radiotherapy in limited stage small cell lung cancer:a Dutch multicenter phase Ⅱ study.Br J Cancer,2006,94:625-630.
  • 10Chen GY,Jiang GL,Wang LJ,et al.Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer:a clinical phase Ⅱ trial.Int J Radiat Oncol Biol Phys,2005,61:70-75.

共引文献59

同被引文献41

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部